tri-weekly cisplatin

DRUG2 trials

Sponsors

Korea Cancer Center Hospital

Conditions

Cervical CancersCervical Neoplasms

Phase 2

Efficacy Study for Postoperative Chemoradiation Using Triweekly Cisplatin in Cervical Cancer Patients

WithdrawnNCT00950261

Korea Cancer Center HospitalCervical Neoplasms

Start: 2009-01-31End: 2012-05-31Updated: 2018-08-13

Phase 3

Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer

CompletedNCT01097252

Korea Cancer Center HospitalCervical Cancers

Start: 2002-01-31End: 2009-12-31Updated: 2014-05-09